INT32962

From wiki-pain
Revision as of 03:13, 21 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.41
First Reported 1985
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 0.59
Pain Relevance 0.49

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (GNRHR) signal transducer activity (GNRHR)
Anatomy Link Frequency
follicle 2
GNRHR (Homo sapiens)
Pain Link Frequency Relevance Heat
Endogenous opioid 2 100.00 Very High Very High Very High
Opioid 6 98.32 Very High Very High Very High
opioid receptor 1 90.00 High High
narcan 3 87.60 High High
anesthesia 2 50.00 Quite Low
epidural 2 50.00 Quite Low
depression 15 5.00 Very Low Very Low Very Low
rheumatoid arthritis 7 5.00 Very Low Very Low Very Low
opiate 4 5.00 Very Low Very Low Very Low
fluoxetine 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Androgen Insensitivity 1 93.48 High High
Turner's Syndrome 1 83.92 Quite High
Virilism 1 78.32 Quite High
Reprotox - General 1 9 76.00 Quite High
Acne 1 72.24 Quite High
Gynecomastia 1 64.96 Quite High
Hypogonadotropic Hypogonadism 17 61.36 Quite High
Testosterone Deficiency 2 28.40 Quite Low
Endometriosis (extended) 4 18.40 Low Low
Aging 14 14.88 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
All patients underwent controlled ovarian hyperstimulation employing human menopausal gonadotropin and gonadotropin releasing hormone agonist, given either in the midluteal or early follicular phase.
Positive_regulation (hyperstimulation) of Localization (releasing) of gonadotropin releasing hormone
1) Confidence 0.41 Published 1998 Journal J Reprod Med Section Body Doc Link 9749419 Disease Relevance 0 Pain Relevance 0
There is also evidence to implicate suprahypothalamic mechanism(s) that enhance endogenous opioid inhibition of secretion of gonadotropin-releasing hormone.
Positive_regulation (enhance) of Localization (secretion) of gonadotropin-releasing hormone associated with endogenous opioid
2) Confidence 0.34 Published 1985 Journal Am. J. Obstet. Gynecol. Section Abstract Doc Link 2990210 Disease Relevance 0 Pain Relevance 0.49
The hypothalamus increases its secretion of gonadotropin releasing hormone (GnRH) which in turn stimulates the release of luteinizing hormone (LH) and follicle stimulating hormone (FSH).
Positive_regulation (increases) of Localization (secretion) of gonadotropin releasing hormone in follicle
3) Confidence 0.15 Published 2007 Journal Clinical Interventions in Aging Section Body Doc Link PMC2686330 Disease Relevance 0.59 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox